Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
IGM Biosciences, Inc. (IGMS)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 150.7 | 140.2 | | 177.4 | 221.3 | 75.4 | 133.3 | 165.6 |
| Short-term investments | | 233.2 | | 291.7 | 291.9 | 112.0 | 96.2 | 93.9 |
| Other current assets | 251.1 | 11.4 | | 10.8 | 8.6 | 10.3 | 11.2 | 8.9 |
| Total current assets | 401.8 | 384.8 | | 480.0 | 521.8 | 197.8 | 240.7 | 268.4 |
| Property, plant, and equipment, net | 38.4 | 36.7 | | 31.9 | 31.3 | 30.0 | 28.5 | 28.2 |
| Long-term investments | | | | | | | | 6.1 |
| Other fixed assets | 2.1 | 2.2 | | 2.1 | 1.0 | 1.0 | 1.0 | 0.9 |
| Total assets | 480.7 | 462.7 | | 540.9 | 582.2 | 257.7 | 298.1 | 332.2 |
| |
| Accounts payable | 4.9 | 4.0 | | 2.7 | 3.5 | 4.0 | 5.6 | 3.3 |
| Accrued expenses | 1.6 | 29.6 | | 32.6 | 24.6 | 19.3 | 1.0 | 13.9 |
| Short-term debt | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other current liabilities | 37.7 | 10.0 | | 9.1 | 7.8 | 4.1 | 21.2 | 3.2 |
| Total current liabilities | 44.3 | 43.6 | | 44.5 | 35.8 | 27.4 | 27.8 | 20.5 |
| Other liabilities | 177.8 | 179.7 | | 168.3 | 171.0 | 25.9 | 25.4 | 26.2 |
| Total liabilities | 222.1 | 223.3 | | 212.8 | 206.8 | 53.2 | 53.2 | 46.7 |
| |
| Shareholders' equity [+] | 258.6 | 239.4 | | 328.2 | 375.4 | 204.5 | 244.9 | 285.6 |
| Paid-in capital | 957.1 | 873.5 | | 850.8 | 839.7 | 610.0 | 598.4 | 588.3 |
| Retained earnings | -698.6 | -634.1 | | -1,044.6 | -464.2 | -405.6 | -353.7 | -303.1 |
| Tangible shareholders' equity | 258.6 | 239.4 | | 328.2 | 375.4 | 204.5 | 244.9 | 285.6 |
|